Read More Healthcare Industry News Inside Johnson & Johnson’s $966m talc verdict: how one case could reshape its future battles Find out how Johnson & Johnson’s $966 million talc cancer verdict could reshape its litigation strategy, investor sentiment, and brand credibility. bySrinathOctober 7, 2025